The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis

Abstract Emerging evidence demonstrates that cryptic translation from RNAs previously annotated as noncoding might generate microproteins with oncogenic functions. However, the importance and underlying mechanisms of these microproteins in alternative splicing-driven tumor progression have rarely be...

Full description

Saved in:
Bibliographic Details
Main Authors: Kun Meng, Yuying Li, Xiaoyi Yuan, Hui-Min Shen, Li-Ling Hu, Danya Liu, Fujin Shi, Dandan Zheng, Xinyu Shi, Nengqiao Wen, Yun Cao, Yun-Long Pan, Qing-Yu He, Chris Zhiyi Zhang
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-025-02128-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571218060902400
author Kun Meng
Yuying Li
Xiaoyi Yuan
Hui-Min Shen
Li-Ling Hu
Danya Liu
Fujin Shi
Dandan Zheng
Xinyu Shi
Nengqiao Wen
Yun Cao
Yun-Long Pan
Qing-Yu He
Chris Zhiyi Zhang
author_facet Kun Meng
Yuying Li
Xiaoyi Yuan
Hui-Min Shen
Li-Ling Hu
Danya Liu
Fujin Shi
Dandan Zheng
Xinyu Shi
Nengqiao Wen
Yun Cao
Yun-Long Pan
Qing-Yu He
Chris Zhiyi Zhang
author_sort Kun Meng
collection DOAJ
description Abstract Emerging evidence demonstrates that cryptic translation from RNAs previously annotated as noncoding might generate microproteins with oncogenic functions. However, the importance and underlying mechanisms of these microproteins in alternative splicing-driven tumor progression have rarely been studied. Here, we show that the novel protein TPM3P9, encoded by the lncRNA tropomyosin 3 pseudogene 9, exhibits oncogenic activity in clear cell renal cell carcinoma (ccRCC) by enhancing oncogenic RNA splicing. Overexpression of TPM3P9 promotes cell proliferation and tumor growth. Mechanistically, TPM3P9 binds to the RRM1 domain of the splicing factor RBM4 to inhibit RBM4-mediated exon skipping in the transcription factor TCF7L2. This results in increased expression of the oncogenic splice variant TCF7L2-L, which activates NF-κB signaling via its interaction with SAM68 to transcriptionally induce RELB expression. From a clinical perspective, TPM3P9 expression is upregulated in cancer tissues and is significantly correlated with the expression of TCF7L2-L and RELB. High TPM3P9 expression or low RBM4 expression is associated with poor survival in patients with ccRCC. Collectively, our findings functionally and clinically characterize the “noncoding RNA”-derived microprotein TPM3P9 and thus identify potential prognostic and therapeutic factors in renal cancer.
format Article
id doaj-art-1c255317cc95452bb453596720357516
institution Kabale University
issn 2059-3635
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Signal Transduction and Targeted Therapy
spelling doaj-art-1c255317cc95452bb4535967203575162025-02-02T12:44:33ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352025-01-0110111710.1038/s41392-025-02128-8The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesisKun Meng0Yuying Li1Xiaoyi Yuan2Hui-Min Shen3Li-Ling Hu4Danya Liu5Fujin Shi6Dandan Zheng7Xinyu Shi8Nengqiao Wen9Yun Cao10Yun-Long Pan11Qing-Yu He12Chris Zhiyi Zhang13MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan UniversityMOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan UniversityMOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan UniversityDepartment of Obstetrics and Gynecology, The First Affiliated Hospital, Sun Yat-sen UniversityMOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan UniversityMOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan UniversityMOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan UniversityMOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan UniversityMOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan UniversityDepartment of Pathology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer CenterDepartment of Pathology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer CenterThe First Affiliated Hospital of Jinan University, Jinan UniversityMOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan UniversityMOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan UniversityAbstract Emerging evidence demonstrates that cryptic translation from RNAs previously annotated as noncoding might generate microproteins with oncogenic functions. However, the importance and underlying mechanisms of these microproteins in alternative splicing-driven tumor progression have rarely been studied. Here, we show that the novel protein TPM3P9, encoded by the lncRNA tropomyosin 3 pseudogene 9, exhibits oncogenic activity in clear cell renal cell carcinoma (ccRCC) by enhancing oncogenic RNA splicing. Overexpression of TPM3P9 promotes cell proliferation and tumor growth. Mechanistically, TPM3P9 binds to the RRM1 domain of the splicing factor RBM4 to inhibit RBM4-mediated exon skipping in the transcription factor TCF7L2. This results in increased expression of the oncogenic splice variant TCF7L2-L, which activates NF-κB signaling via its interaction with SAM68 to transcriptionally induce RELB expression. From a clinical perspective, TPM3P9 expression is upregulated in cancer tissues and is significantly correlated with the expression of TCF7L2-L and RELB. High TPM3P9 expression or low RBM4 expression is associated with poor survival in patients with ccRCC. Collectively, our findings functionally and clinically characterize the “noncoding RNA”-derived microprotein TPM3P9 and thus identify potential prognostic and therapeutic factors in renal cancer.https://doi.org/10.1038/s41392-025-02128-8
spellingShingle Kun Meng
Yuying Li
Xiaoyi Yuan
Hui-Min Shen
Li-Ling Hu
Danya Liu
Fujin Shi
Dandan Zheng
Xinyu Shi
Nengqiao Wen
Yun Cao
Yun-Long Pan
Qing-Yu He
Chris Zhiyi Zhang
The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis
Signal Transduction and Targeted Therapy
title The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis
title_full The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis
title_fullStr The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis
title_full_unstemmed The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis
title_short The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis
title_sort cryptic lncrna encoded microprotein tpm3p9 drives oncogenic rna splicing and tumorigenesis
url https://doi.org/10.1038/s41392-025-02128-8
work_keys_str_mv AT kunmeng thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT yuyingli thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT xiaoyiyuan thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT huiminshen thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT lilinghu thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT danyaliu thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT fujinshi thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT dandanzheng thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT xinyushi thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT nengqiaowen thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT yuncao thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT yunlongpan thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT qingyuhe thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT chriszhiyizhang thecrypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT kunmeng crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT yuyingli crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT xiaoyiyuan crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT huiminshen crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT lilinghu crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT danyaliu crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT fujinshi crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT dandanzheng crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT xinyushi crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT nengqiaowen crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT yuncao crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT yunlongpan crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT qingyuhe crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis
AT chriszhiyizhang crypticlncrnaencodedmicroproteintpm3p9drivesoncogenicrnasplicingandtumorigenesis